Total Funding
43
44
Total FundingPost-IPO Equity raised
Growth Score
-2 pts
Heat Score
-2 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
184901
Ixico is a U.K.-based company that provides clinical trial services worldwide.
- Andy Richards: Chairman
- Grant Nash: CFO
About the Company
Ixico is a U.K.-based company that provides clinical trial services worldwide. The company offers end-to-end imaging services in various therapeutic areas, primarily in the fields of oncology and neurology to the pharmaceutical industry, biotech companies, academia, and medical charities.
Ixico offers technology developing solutions for the
treatment of diseases, including predominantly dementia and other neuro degeneration diseases. It is based in London, England.
